More articles from Idiopathic interstitial pneumonias

Histological and molecular characterization of lung cancer (LC) in patients with and without interstitial lung disease (ILD)
Gioele Castelli, Matteo Scordari, Nicol Bernardinello, Elisabetta Cocconcelli, Mariaenrica Tinè, Giulia Grisostomi, Serena Bellani, Fiorella Calabrese, Paolo Spagnolo, Elisabetta Balestro

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1149; DOI: 10.1183/13993003.congress-2023.PA1149
Osteopontin as a biomarker in interstitial lung diseases
Verónica Pulito Cueto, David Iturbe Fernández, Víctor Manuel Mora Cuesta, Sara Remuzgo Martínez, Diego José Ferrer Pargada, José Manuel Cifrián Martínez, Raquel López Mejías, Fernanda Genre, Sandra Tello Mena, María Sebastián Mora-Gil, Sheila Izquierdo Cuervo, Miguel Ángel González-Gay Mantecón

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1140; DOI: 10.1183/13993003.congress-2023.PA1140
Differential blood count as a prognostic tool in interstitial lung diseases
Nimrod Orr Urtreger, Ophir Freund, Tzlil Hershko, Liran Levy, Amir Bar-Shai, Avraham Unterman

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1137; DOI: 10.1183/13993003.congress-2023.PA1137
Lactate dehydrogenase predicts disease progression in patients with IPF
Nils Hoyer, Michael Brun Andersen, Lene Collatz, Emilia Kassandra Achilles Åttingsberg, Saher Burhan Shaker

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1143; DOI: 10.1183/13993003.congress-2023.PA1143
A combined measure of blood leukocytes, FVC and quantitative CT is highly predictive of mortality in idiopathic pulmonary fibrosis (IPF)
Andrew Achaiah, Emily Fraser, Peter Saunders, Rachel Hoyles, Rachel Benamore, Ling-Pei Ho

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1133; DOI: 10.1183/13993003.congress-2023.PA1133
CT-derived biomarkers as predictors of overall survival in patients with idiopathic pulmonary fibrosis (IPF)
Francesco Bonella, Luca Salhöfer, Mathias Meetschen, Lale Umutlu, Michael Forsting, Benedikt Schaarschmidt, Marcel Opitz, Rene Hosch, Sven Koitka, Vicky Parmar, Felix Nensa, Johannes Haubold

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1131; DOI: 10.1183/13993003.congress-2023.PA1131
Circulating prostasin associates with presence and severity of idiopathic pulmonary fibrosis (IPF)
Jamie Todd, Hillary Mulder, Megan L Neely, John A Belperio, Joseph A Lasky, Tracy R Luckhardt, Scott M Palmer, Christian Hesslinger, Thomas Schlange, Thomas B Leonard

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1144; DOI: 10.1183/13993003.congress-2023.PA1144
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis
Lucia Vietri, Miriana D'Alessandro, Laura Bergantini, Paolo Cameli, Elena Bargagli

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1142; DOI: 10.1183/13993003.congress-2023.PA1142
Associations between neutrophil and lymphocyte counts and ILD progression in subjects with progressive fibrosing ILDs
Michael Kreuter, Justin M Oldham, Claudia Valenzuela, Takafumi Suda, Heiko Müller, Kamila Sroka-Saidi, Toby M Maher

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1136; DOI: 10.1183/13993003.congress-2023.PA1136
Blood gene expression is associated with decline in lung function in interstitial lung disease
Daniel He, Boyang Zheng, Scott J Tebbutt, Christopher J Ryerson

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1135; DOI: 10.1183/13993003.congress-2023.PA1135

Main menu

User menu

Search

More articles from Idiopathic interstitial pneumonias

Pages

Contact us